Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP vs NITROFURAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB-ALIP vs NITROFURAZONE: Safety Overview

Metric NIRSEVIMAB-ALIP NITROFURAZONE
Total FAERS Reports 783 307
Deaths Reported 32 298
Death Rate 4.1% 97.1%
Hospitalizations 281 87
Average Patient Age 3.3 yrs 44.0 yrs
% Female Patients 46.3% 99.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Marketing Status Prescription Discontinued